“Appropriate Doses Treatment” of IncobotulinumtoxinA in spasticity
Objective: The aim of this study is to object the efficiency and safety of 100 to 1000 units botulinum toxin treatment with modulation of spasticity…The Use of eConsult in a Movement Disorders Clinic
Objective: To assess the use of eConsults in a Movement Disorders clinic. Background: The availability of specialized care in most regions is limited and novel…Safety and efficacy of high definition tDCS for proprioception and balance in Parkinson’s disease: A pilot randomised trial
Objective: To determine: 1. Is HD-tDCS safe and well-tolerated in PD? 2. Does combined HD-tDCS and physical exercise improve proprioception and balance in PD? Background:…Which is the best condition to evaluate the decline in gait automaticity in people with Parkinson’s disease? A ParkiMob study
Objective: To identify which is the most efficient condition in terms of distance and kind of concurrent task to identify the decline in gait automaticity…Accelerometer-based measures and analyses of nonmotor symptoms of patients with Parkinson’s Disease
Objective: Through the monitoring of patients with PD during ON and OFF states, we aim at studying the detection of nonmotor symptoms (NMS) changes during…Characteristics of leg tremors on standing in primary orthostatic tremor and Parkinson’s disease
Objective: To clarify the characteristics of leg tremors in cases with primary orthostatic tremor (OT) and Parkinson’s disease (PD) using surface electromyography (SEMG) with modifications…Imaging neurodegeneration biomarkers in Essential Tremor
Objective: To find neuroimaging biomarkers of neurodegeration in patients with essential tremor (ET). Background: ET is one of the most common movement disorder. The disease…FXTAS-like Phenotype with p.P626L Missense Mutation: A case report
Objective: To describe p.P626L missense mutation of FMR1 gene in a patient with clinical phenotype of Fragile X Associated Tremor and Ataxia Syndrome (FXTAS). Background:…The analysis of cognitive impairment associated with Parkinson’s disease
Objective: The study was to investigate the traits, the related factors and the impact on quality of life of cognitive impairment associated with Parkinson's disease.…Amyloid deposition affects cognitive manifestations in Parkinson’s disease: The PPMI dataset
Objective: To investigate the contribution of amyloid depositions to cognitive deficits in the early phase of Parkinson’s disease (PD). Background: Involvement of amyloid deposits is…
- « Previous Page
- 1
- …
- 149
- 150
- 151
- 152
- 153
- …
- 177
- Next Page »